The generation and characterization of mice expressing a plasmin-inactivating active site mutation

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 10, 2010, Pages 2341-2344

  Iwaki, T ^a   Malinverno, C ^a   Smith, D ^a   Xu, Z ^a   Liang, Z ^a   Ploplis, V A ^a   Castellino, F J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN;

EXON; GENE DELETION; GENE LOCUS; GENE MUTATION; GENOTYPE; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME;

ANIMALS; BODY SIZE; CATALYTIC DOMAIN; CHROMOSOMES, ARTIFICIAL, BACTERIAL; FIBRINOLYSIN; HEMOSTASIS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, GENETIC; MUTATION; PHENOTYPE; PROTEIN BINDING;

EID: 78649385285     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03995.x     Document Type: Letter

References (27)

1. Castellino FJ, Ploplis VA. Human plasminogen: structure, activation, and function. In:Waisman DM, ed. Plasminogen Structure, Activation, and Regulation. NewYork, NY: Kluwer Academic/PlenumPublishers, 2003: 3-17.
2. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plague. Science 1992; 258: 1004-7.
3. Schott D, Dempfle CE, Beck P, Liermann A, Mohr-Pennert A, Goldner M, Mehlem P, Azuma H, Schuster V, Mingers AM, Schwarz HP, Kramer MD. Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. N Engl J Med 1998; 339: 1679-86.
4. Drew AF, Kaufman AH, Kombrinck KW, Danton MJS, Daugherty CC, Degen JL, Bugge TH. Ligneous conjunctivitis in plasminogendeficient mice. Blood 1998; 91: 1616-24.
5. Atkinson SJ, Ward RV, Reynolds JJ, Murphy G. Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. Biochem J 1992; 288 (Pt 2): 605-11.
6. Murphy G, Atkinson S, Ward R, Gavrilovic J, Reynolds JJ. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann NY Acad Sci 1992; 667: 1-12.
7. Campbell PG, Andress DL. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): regulation by IGFBP-5-(201-218). Am J Physiol 1997; 273: E996-1004.
8. Rifkin DB, Mazzieri R, Munger JS, Noguera I, Sung J. Proteolytic control of growth factor availability. APMIS 1999; 107: 80-5.
9. Heinz HP, Loos M. Activation of the first component of complement, C1: comparison of the effect of sixteen different enzymes on serum C1. Immunobiology 1983; 165: 175-85.
10. Miles LA, Hawley SB, Baik N, Andronicos NM, Castellino FJ, Parmer RJ. Plasminogen receptors: the sine qua non of cell surface plasminogen activation. Front Biosci 2005; 10: 1754-62.
11. Ranson M, Andronicos NM, O'Mullane MJ, Baker MS. Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins. Br J Cancer 1998; 77: 1586-97.
12. Ullberg M, Kronvall G, Wiman B. New receptor for human plasminogen on gram positive cocci. APMIS 1989; 97: 996-1002.
13. Ullberg M, Kronvall G, Karlsson I, Wiman B. Receptors for human plasminogen on gram-negative bacteria. Infect Immun 1990; 58: 21-5.
14. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of a-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682-91.
15. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen tissue plasminogen activator. 1. Identity with annexin II. J Biol Chem 1994; 269: 21191-7.
16. Wistedt AC, Kotarsky H, Marti D, Ringdahl U, Castellino FJ, Schaller J, Sjobring U. Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM. J Biol Chem 1998; 273: 24420-4.
17. Rios-Steiner JL, Schenone M, Mochalkin I, Tulinsky A, Castellino FJ. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol 2001; 308: 705-19.
18. Bugge TH, Lund LR, Kombrinck KK, Nielsen BS, Holmback K, Drew AF, Flick MJ, Witte DP, Dano K, Degen JL. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice. Oncogene 1998; 16: 3097-104.
19. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
20. Bugge TH, Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995; 9: 794-807.
21. Ploplis VA, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health inmice. Circulation 1995; 92: 2585-93.
22. Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin system. Thromb Haemost 2005; 93: 647-54.
23. Bugge TH, Kombrinck KW, Flick MJ, Daugherty CC, Danton MJ, Degen JL. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996; 87: 709-19.
24. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res 2005; 33: e36.
25. Yanagawa Y, Kobayashi T, Ohnishi M, Kobayashi T, Tamura S, Tsuzuki T, Sanbo M, Yagi T, Tashiro F, Miyazaki J. Enrichment and efficient screening of ES cells containing a targetedmutation: the use of DT-A gene with the polyadenylation signal as a negative selection maker. Transgenic Res 1999; 8: 215-21.
26. Lijnen HR, Van Hoef B, De Coek F, Okada K, Ueshima S, Matsuo O, Collen D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 1991; 266: 11826-32.
27. Horrevoets AJG, Pannekoek H, Nesheim ME. Production and characterization of recombinant human plasminogen(S741C-Fluorescein). A novel approach to study zymogen activation without generation of active protease. J Biol Chem 1997; 272: 2176-82.